Related Experiment Video

Updated: Oct 10, 2025

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.2K

Identified Three Interferon Induced Proteins as Novel Biomarkers of Human Ischemic Cardiomyopathy

Cheng Chen1,2, Jiao Tian1,3, Zhicheng He1,2

  • 1State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China.

International Journal of Molecular Sciences
|December 10, 2021
PubMed

Insights

Researchers identified three interferon-stimulated genes (IFIT2, IFIT3, IFI44L) as potential biomarkers and therapeutic targets for ischemic cardiomyopathy, offering new avenues for precise cardiac disorder diagnosis and treatment.

Area of Science:

  • Cardiology
  • Genomics
  • Molecular Biology

Background:

  • Ischemic cardiomyopathy is a leading cause of heart failure and myocardial infarction.
  • Current diagnostic and therapeutic strategies require improvement through precise biomarkers and targets.
  • Identifying novel genetic factors is crucial for advancing treatment for this prevalent heart condition.

Purpose of the Study:

  • To identify novel gene signatures and pathways associated with ischemic cardiomyopathy.
  • To explore potential biomarkers and therapeutic targets for precise clinical applications.
  • To validate identified genes in a preclinical model and assess their link to cardiovascular disorders.

Main Methods:

  • Transcriptional profiling of 313 left ventricle biopsies from the PubMed database.
  • Weighted Gene Co-Expression Network Analysis and protein-protein interaction network enrichment analysis.
  • Validation using a rat myocardial infarction model and analysis via the Cardiovascular Disease Knowledge Portal.

Main Results:

  • Three interferon-stimulated genes (IFIT2, IFIT3, and IFI44L) were identified as significantly related to ischemic cardiomyopathy.
  • These genes and associated pathways were confirmed to be strongly linked to cardiac disorders.
  • The identified signature genes show potential for clinical utility in diagnosis and treatment.

Conclusions:

  • IFIT2, IFIT3, and IFI44L represent novel potential biomarkers and therapeutic targets for ischemic cardiomyopathy.
  • These findings pave the way for more precise clinical diagnosis and treatment strategies.
  • Further research into these genes could significantly impact the management of ischemic cardiomyopathy and related cardiac conditions.

Keywords:
IFIT2/3WGCNAheart failureinterferon stimulated genesischemic cardiomyopathy

More Related Videos

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

16.8K
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.2K

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
390
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
41
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
255
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
61
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
86